199 related articles for article (PubMed ID: 12095160)
1. Cytochrome C and caspase-9 expression in Huntington's disease.
Kiechle T; Dedeoglu A; Kubilus J; Kowall NW; Beal MF; Friedlander RM; Hersch SM; Ferrante RJ
Neuromolecular Med; 2002; 1(3):183-95. PubMed ID: 12095160
[TBL] [Abstract][Full Text] [Related]
2. Death of cortical and striatal neurons induced by mitochondrial defect involves differential molecular mechanisms.
Galas MC; Bizat N; Cuvelier L; Bantubungi K; Brouillet E; Schiffmann SN; Blum D
Neurobiol Dis; 2004 Feb; 15(1):152-9. PubMed ID: 14751780
[TBL] [Abstract][Full Text] [Related]
3. Overexpression of copper/zinc superoxide dismutase in transgenic rats protects vulnerable neurons against ischemic damage by blocking the mitochondrial pathway of caspase activation.
Sugawara T; Noshita N; Lewén A; Gasche Y; Ferrand-Drake M; Fujimura M; Morita-Fujimura Y; Chan PH
J Neurosci; 2002 Jan; 22(1):209-17. PubMed ID: 11756504
[TBL] [Abstract][Full Text] [Related]
4. Expression pattern of apoptosis-related markers in Huntington's disease.
Vis JC; Schipper E; de Boer-van Huizen RT; Verbeek MM; de Waal RM; Wesseling P; ten Donkelaar HJ; Kremer B
Acta Neuropathol; 2005 Mar; 109(3):321-8. PubMed ID: 15668790
[TBL] [Abstract][Full Text] [Related]
5. Cardiac Fas-Dependent and Mitochondria-Dependent Apoptotic Pathways in a Transgenic Mouse Model of Huntington's Disease.
Wu BT; Chiang MC; Tasi CY; Kuo CH; Shyu WC; Kao CL; Huang CY; Lee SD
Cardiovasc Toxicol; 2016 Apr; 16(2):111-21. PubMed ID: 25800750
[TBL] [Abstract][Full Text] [Related]
6. Glutamate-induced apoptosis in primary cortical neurons is inhibited by equine estrogens via down-regulation of caspase-3 and prevention of mitochondrial cytochrome c release.
Zhang Y; Bhavnani BR
BMC Neurosci; 2005 Feb; 6():13. PubMed ID: 15730564
[TBL] [Abstract][Full Text] [Related]
7. Increased calbindin-D28k immunoreactivity in striatal projection neurons of R6/2 Huntington's disease transgenic mice.
Sun Z; Wang HB; Deng YP; Lei WL; Xie JP; Meade CA; Del Mar N; Goldowitz D; Reiner A
Neurobiol Dis; 2005 Dec; 20(3):907-17. PubMed ID: 15990326
[TBL] [Abstract][Full Text] [Related]
8. Intracellular Bax translocation after transient cerebral ischemia: implications for a role of the mitochondrial apoptotic signaling pathway in ischemic neuronal death.
Cao G; Minami M; Pei W; Yan C; Chen D; O'Horo C; Graham SH; Chen J
J Cereb Blood Flow Metab; 2001 Apr; 21(4):321-33. PubMed ID: 11323518
[TBL] [Abstract][Full Text] [Related]
9. Modulation of apoptotic regulatory proteins and early activation of cytochrome C following systemic 3-nitropropionic acid administration.
Antonawich FJ; Fiore-Marasa SM; Parker CP
Brain Res Bull; 2002 Mar; 57(5):647-9. PubMed ID: 11927368
[TBL] [Abstract][Full Text] [Related]
10. Electrophysiological and morphological changes in striatal spiny neurons in R6/2 Huntington's disease transgenic mice.
Klapstein GJ; Fisher RS; Zanjani H; Cepeda C; Jokel ES; Chesselet MF; Levine MS
J Neurophysiol; 2001 Dec; 86(6):2667-77. PubMed ID: 11731527
[TBL] [Abstract][Full Text] [Related]
11. Huntington's disease: Neural dysfunction linked to inositol polyphosphate multikinase.
Ahmed I; Sbodio JI; Harraz MM; Tyagi R; Grima JC; Albacarys LK; Hubbi ME; Xu R; Kim S; Paul BD; Snyder SH
Proc Natl Acad Sci U S A; 2015 Aug; 112(31):9751-6. PubMed ID: 26195796
[TBL] [Abstract][Full Text] [Related]
12. Manganese Superoxide Dismutase Affects Cytochrome c Release and Caspase-9 Activation After Transient Focal Cerebral Ischemia in Mice.
Noshita N; Sugawara T; Fujimura M; Morita-Fujimura Y; Chan PH
J Cereb Blood Flow Metab; 2001 May; 21(5):557-67. PubMed ID: 11333366
[TBL] [Abstract][Full Text] [Related]
13. Caspase-dependent cytosolic release of cytochrome c and membrane translocation of Bax in p53-induced apoptosis.
Gao CF; Ren S; Zhang L; Nakajima T; Ichinose S; Hara T; Koike K; Tsuchida N
Exp Cell Res; 2001 Apr; 265(1):145-51. PubMed ID: 11281652
[TBL] [Abstract][Full Text] [Related]
14. Afferent regulation of cytochrome-c and active caspase-9 in the avian cochlear nucleus.
Wilkinson BL; Elam JS; Fadool DA; Hyson RL
Neuroscience; 2003; 120(4):1071-9. PubMed ID: 12927212
[TBL] [Abstract][Full Text] [Related]
15. Chronology of behavioral symptoms and neuropathological sequela in R6/2 Huntington's disease transgenic mice.
Stack EC; Kubilus JK; Smith K; Cormier K; Del Signore SJ; Guelin E; Ryu H; Hersch SM; Ferrante RJ
J Comp Neurol; 2005 Oct; 490(4):354-70. PubMed ID: 16127709
[TBL] [Abstract][Full Text] [Related]
16. Caspases in Huntington's disease.
Sanchez Mejia RO; Friedlander RM
Neuroscientist; 2001 Dec; 7(6):480-9. PubMed ID: 11765125
[TBL] [Abstract][Full Text] [Related]
17. AMPK-α1 functions downstream of oxidative stress to mediate neuronal atrophy in Huntington's disease.
Ju TC; Chen HM; Chen YC; Chang CP; Chang C; Chern Y
Biochim Biophys Acta; 2014 Sep; 1842(9):1668-80. PubMed ID: 24946181
[TBL] [Abstract][Full Text] [Related]
18. FK506 ameliorates cell death features in Huntington's disease striatal cell models.
Rosenstock TR; de Brito OM; Lombardi V; Louros S; Ribeiro M; Almeida S; Ferreira IL; Oliveira CR; Rego AC
Neurochem Int; 2011 Oct; 59(5):600-9. PubMed ID: 21703318
[TBL] [Abstract][Full Text] [Related]
19. Reovirus-induced neuronal apoptosis is mediated by caspase 3 and is associated with the activation of death receptors.
Richardson-Burns SM; Kominsky DJ; Tyler KL
J Neurovirol; 2002 Oct; 8(5):365-80. PubMed ID: 12402163
[TBL] [Abstract][Full Text] [Related]
20. 'Tissue' transglutaminase ablation reduces neuronal death and prolongs survival in a mouse model of Huntington's disease.
Mastroberardino PG; Iannicola C; Nardacci R; Bernassola F; De Laurenzi V; Melino G; Moreno S; Pavone F; Oliverio S; Fesus L; Piacentini M
Cell Death Differ; 2002 Sep; 9(9):873-80. PubMed ID: 12181738
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
